Dong-Qing Wei

InstitutionShanghai Jiaotong University
AddressShanghai
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 23 Covid-19 publications, with a maximum of 3 publications in June 2020 and January 2021
    All Publications
    Bar chart showing 172 publications over 19 distinct years, with a maximum of 21 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Kaushik AC, Mehmood A, Selvaraj G, Dai X, Pan Y, Wei DQ. CoronaPep: An Anti-Coronavirus Peptide Generation Tool. IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug; 18(4):1299-1304. PMID: 33687847.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    2. Zhou D, Peng S, Wei DQ, Zhong W, Dou Y, Xie X. LUNAR :Drug Screening for Novel Coronavirus Based on Representation Learning Graph Convolutional Network. IEEE/ACM Trans Comput Biol Bioinform. 2021 Jul-Aug; 18(4):1290-1298. PMID: 34081583.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    3. Khan A, Umbreen S, Hameed A, Fatima R, Zahoor U, Babar Z, Waseem M, Hussain Z, Rizwan M, Zaman N, Ali S, Suleman M, Shah A, Ali L, Ali SS, Wei DQ. In Silico Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: Structural-Dynamics and Free Energy Calculations. Interdiscip Sci. 2021 Sep; 13(3):521-534. PMID: 34324157.
      Citations: 1     Fields:    Translation:HumansCells
    4. Khan A, Wei DQ, Kousar K, Abubaker J, Ahmad S, Ali J, Al-Mulla F, Ali SS, Nizam-Uddin N, Mohammad Sayaf A, Mohammad A. Preliminary Structural Data Revealed That the SARS-CoV-2 B.1.617 Variant's RBD Binds to ACE2 Receptor Stronger Than the Wild Type to Enhance the Infectivity. Chembiochem. 2021 08 17; 22(16):2641-2649. PMID: 34160124.
      Citations: 7     Fields:    Translation:HumansCells
    5. Kaliamurthi S, Selvaraj G, Selvaraj C, Singh SK, Wei DQ, Peslherbe GH. Structure-Based Virtual Screening Reveals Ibrutinib and Zanubrutinib as Potential Repurposed Drugs against COVID-19. Int J Mol Sci. 2021 Jun 30; 22(13). PMID: 34209188.
      Citations: 2     Fields:    Translation:HumansCells
    6. Mohammad A, Al-Mulla F, Wei DQ, Abubaker J. Remdesivir MD Simulations Suggest a More Favourable Binding to SARS-CoV-2 RNA Dependent RNA Polymerase Mutant P323L Than Wild-Type. Biomolecules. 2021 06 22; 11(7). PMID: 34206274.
      Citations:    Fields:    Translation:HumansCells
    7. Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights. Interdiscip Sci. 2021 Jun; 13(2):344-347. PMID: 34021862.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    8. Khan A, Khan S, Saleem S, Nizam-Uddin N, Mohammad A, Khan T, Ahmad S, Arshad M, Ali SS, Suleman M, Wei DQ. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation. Comput Biol Med. 2021 06; 133:104420. PMID: 33930764.
      Citations: 8     Fields:    Translation:Humans
    9. Khan A, Zia T, Suleman M, Khan T, Ali SS, Abbasi AA, Mohammad A, Wei DQ. Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data. J Cell Physiol. 2021 10; 236(10):7045-7057. PMID: 33755190.
      Citations: 47     Fields:    Translation:HumansCells
    10. Stalin A, Lin D, Senthamarai Kannan B, Feng Y, Wang Y, Zhao W, Ignacimuthu S, Wei DQ, Chen Y. An in-silico approach to identify the potential hot spots in SARS-CoV-2 spike RBD to block the interaction with ACE2 receptor. J Biomol Struct Dyn. 2021 Mar 09; 1-16. PMID: 33685364.
      Citations: 3     Fields:    
    11. Selvaraj G, Kaliamurthi S, Peslherbe GH, Wei DQ. Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches. F1000Res. 2021; 10:127. PMID: 33968364.
      Citations: 1     Fields:    Translation:HumansCells
    12. Khan S, Hussain Z, Safdar M, Khan A, Wei DQ. Targeting the N-terminal domain of the RNA-binding protein of the SARS-CoV-2 with high affinity natural compounds to abrogate the protein-RNA interaction: a molecular dynamics study. J Biomol Struct Dyn. 2021 Feb 08; 1-9. PMID: 33554747.
      Citations:    Fields:    
    13. Khan A, Khan M, Ullah S, Wei DQ. Hantavirus: The Next Pandemic We Are Waiting For? Interdiscip Sci. 2021 Mar; 13(1):147-152. PMID: 33486690.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    14. Khan A, Heng W, Wang Y, Qiu J, Wei X, Peng S, Saleem S, Khan M, Ali SS, Wei DQ. In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro). Phytother Res. 2021 06; 35(6):2841-2845. PMID: 33448101.
      Citations: 15     Fields:    Translation:HumansCells
    15. Khan MT, Irfan M, Ahsan H, Ahmed A, Kaushik AC, Khan AS, Chinnasamy S, Ali A, Wei DQ. Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets. Intervirology. 2021; 64(2):55-68. PMID: 33454715.
      Citations: 4     Fields:    Translation:Humans
    16. Hussain I, Pervaiz N, Khan A, Saleem S, Shireen H, Wei DQ, Labrie V, Bao Y, Abbasi AA. Evolutionary and structural analysis of SARS-CoV-2 specific evasion of host immunity. Genes Immun. 2020 12; 21(6-8):409-419. PMID: 33273723.
      Citations: 9     Fields:    Translation:Humans
    17. Khan A, Tahir Khan M, Saleem S, Junaid M, Ali A, Shujait Ali S, Khan M, Wei DQ. Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein. Comput Struct Biotechnol J. 2020; 18:2174-2184. PMID: 32837710.
      Citations: 19     
    18. Khan MT, Zeb MT, Ahsan H, Ahmed A, Ali A, Akhtar K, Malik SI, Cui Z, Ali S, Khan AS, Ahmad M, Wei DQ, Irfan M. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study. Arch Microbiol. 2021 Jan; 203(1):59-66. PMID: 32749662.
      Citations: 10     Fields:    Translation:HumansCells
    19. Khan A, Khan M, Saleem S, Babar Z, Ali A, Khan AA, Sardar Z, Hamayun F, Ali SS, Wei DQ. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products. Interdiscip Sci. 2020 Sep; 12(3):335-348. PMID: 32617855.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic Health
    20. Khan A, Ali SS, Khan MT, Saleem S, Ali A, Suleman M, Babar Z, Shafiq A, Khan M, Wei DQ. Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro). J Biomol Struct Dyn. 2021 08; 39(13):4659-4670. PMID: 32552361.
      Citations: 22     Fields:    Translation:HumansCells
    21. Quimque MTJ, Notarte KIR, Fernandez RAT, Mendoza MAO, Liman RAD, Lim JAK, Pilapil LAE, Ong JKH, Pastrana AM, Khan A, Wei DQ, Macabeo APG. Virtual screening-driven drug discovery of SARS-CoV2 enzyme inhibitors targeting viral attachment, replication, post-translational modification and host immunity evasion infection mechanisms. J Biomol Struct Dyn. 2021 Aug; 39(12):4316-4333. PMID: 32476574.
      Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
    22. Khan MT, Ali A, Wang Q, Irfan M, Khan A, Zeb MT, Zhang YJ, Chinnasamy S, Wei DQ. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2-a molecular dynamic study. J Biomol Struct Dyn. 2021 07; 39(10):3627-3637. PMID: 32410504.
      Citations: 34     Fields:    Translation:Cells
    23. Wang C, Wang S, Li D, Wei DQ, Zhao J, Wang J. Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2. Gastroenterology. 2020 09; 159(3):1145-1147.e4. PMID: 32437749.
      Citations: 33     Fields:    Translation:HumansCellsPHPublic Health
    24. Wei DQ, Zhang R, Du QS, Gao WN, Li Y, Gao H, Wang SQ, Zhang X, Li AX, Sirois S, Chou KC. Anti-SARS drug screening by molecular docking. Amino Acids. 2006 Jul; 31(1):73-80. PMID: 16715412.
      Citations: 10     Fields:    Translation:Cells
    25. Zhang R, Wei DQ, Du QS, Chou KC. Molecular modeling studies of peptide drug candidates against SARS. Med Chem. 2006 May; 2(3):309-14. PMID: 16948478.
      Citations: 13     Fields:    Translation:Cells
    26. Chou KC, Wei DQ, Du QS, Sirois S, Zhong WZ. Progress in computational approach to drug development against SARS. Curr Med Chem. 2006; 13(27):3263-70. PMID: 17168850.
      Citations: 23     Fields:    Translation:Humans
    27. Gan YR, Huang H, Huang YD, Rao CM, Zhao Y, Liu JS, Wu L, Wei DQ. Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase. Peptides. 2006 Apr; 27(4):622-5. PMID: 16242214.
      Citations: 15     Fields:    Translation:AnimalsCells
    28. Du Q, Wang S, Jiang Z, Gao W, Li Y, Wei D, Chou KC. Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides. Med Chem. 2005 May; 1(3):209-13. PMID: 16787316.
      Citations: 4     Fields:    Translation:Cells
    29. Du Q, Wang S, Wei D, Sirois S, Chou KC. Molecular modeling and chemical modification for finding peptide inhibitor against severe acute respiratory syndrome coronavirus main proteinase. Anal Biochem. 2005 Feb 15; 337(2):262-70. PMID: 15691506.
      Citations: 25     Fields:    Translation:Cells
    30. Du QS, Wang SQ, Zhu Y, Wei DQ, Guo H, Sirois S, Chou KC. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. Peptides. 2004 Nov; 25(11):1857-64. PMID: 15501516.
      Citations: 20     Fields:    Translation:Cells
    31. Sirois S, Wei DQ, Du Q, Chou KC. Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. J Chem Inf Comput Sci. 2004 May-Jun; 44(3):1111-22. PMID: 15154780.
      Citations: 33     Fields:    Translation:Cells
    32. Chou KC, Wei DQ, Zhong WZ. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem Biophys Res Commun. 2003 Aug 15; 308(1):148-51. PMID: 12890493.
      Citations: 76     Fields:    Translation:Cells
    Wei's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (257)
    Explore
    _
    Co-Authors (121)
    Explore
    _
    Similar People (60)
    Explore
    _